1.19 USD
↗ 0.05 (4.39%)AT CLOSE (11:59 AM EDT)
Pliant Therapeutics, Inc. Common Stock
PLRXNASDAQ • USD
1.20
↗ 0.01 (0.42%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
1.20
↗ 0.01 (0.42%)
Market: OPEN
Pliant Therapeutics, Inc. Common Stock (PLRX) trades at $1.20 per share. The stock presents a mixed profile: our models indicate a Strong Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Aug 25, 2026.
Open?$1.14
High?$1.20
Low?$1.13
Prev. Close?$1.14
Volume?322.0K
Avg. Volume?548.1K
VWAP?$1.15
Rel. Volume?0.59x
Bid / Ask
Bid?$1.01 × 100
Ask?$1.37 × 100
Spread?$0.36
Midpoint?$1.19
Valuation & Ratios
Market Cap?70.6M
Shares Out?61.9M
Float?54.3M
Float %?87.7%
P/E Ratio?N/A
P/B Ratio?0.48
EPS?-$1.49
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
Employees
49
Market Cap
70.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2020-06-03
Address
331 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-481-6770
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-481-6770
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?42
Piotroski F-Score?0/9Weak
Altman Z-Score?-6.43Distress
Confidence?44%Low
Short InterestHigh
Short % of Float?5.10%Elevated
Short Interest?2.8M
Days to Cover?7.7
Free Float54.3M
Avg Daily Volume361.8K
Settlement Date2026-08-14
Financial Health
Current Ratio?9.90Strong
Quick Ratio?9.90Strong
Cash Ratio?1.51Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.48CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.5CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-62.8%WEAK▾
S&P3
ROA?-48.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-70895000
Enterprise Value?$45.7M
Fundamentals ratios updated end of day